Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

203 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Hypofractionated radiotherapy alone with 2.4 Gy per fraction for head and neck cancer during the COVID-19 pandemic: The Princess Margaret experience and proposal.
Huang SH, O'Sullivan B, Su J, Ringash J, Bratman SV, Kim J, Hosni A, Bayley A, Cho J, Giuliani M, Hope A, Spreafico A, Hansen AR, Siu LL, Gilbert R, Irish JC, Goldstein D, de Almeida J, Tong L, Xu W, Waldron J. Huang SH, et al. Among authors: bayley a. Cancer. 2020 Aug 1;126(15):3426-3437. doi: 10.1002/cncr.32968. Epub 2020 Jun 1. Cancer. 2020. PMID: 32478895 Free PMC article. Clinical Trial.
Results of radiotherapy for primary subglottic squamous cell carcinoma.
Paisley S, Warde PR, O'Sullivan B, Waldron J, Gullane PJ, Payne D, Liu FF, Bayley A, Ringash J, Cummings BJ. Paisley S, et al. Among authors: bayley a. Int J Radiat Oncol Biol Phys. 2002 Apr 1;52(5):1245-50. doi: 10.1016/s0360-3016(01)02759-6. Int J Radiat Oncol Biol Phys. 2002. PMID: 11955735
A Phase III placebo-controlled trial of oral pilocarpine in patients undergoing radiotherapy for head-and-neck cancer.
Warde P, O'Sullivan B, Aslanidis J, Kroll B, Lockwood G, Waldron J, Payne D, Bayley A, Ringash J, Kim J, Liu FF, Maxymiw W, Sprague S, Cummings BJ. Warde P, et al. Among authors: bayley a. Int J Radiat Oncol Biol Phys. 2002 Sep 1;54(1):9-13. doi: 10.1016/s0360-3016(02)02890-0. Int J Radiat Oncol Biol Phys. 2002. PMID: 12182969 Clinical Trial.
Tolerability of the Intergroup 0099 (INT 0099) regimen in locally advanced nasopharyngeal cancer with a focus on patients' nutritional status.
Bahl M, Siu LL, Pond GR, Kim J, Tannock IF, Bayley A, Cummings BJ, Waldron J, Ringash J, Chen EX, Gitterman L, Lemon B, O'Sullivan B. Bahl M, et al. Among authors: bayley a. Int J Radiat Oncol Biol Phys. 2004 Nov 15;60(4):1127-36. doi: 10.1016/j.ijrobp.2004.05.011. Int J Radiat Oncol Biol Phys. 2004. PMID: 15519784
Phase II trial of hypofractionated image-guided intensity-modulated radiotherapy for localized prostate adenocarcinoma.
Martin JM, Rosewall T, Bayley A, Bristow R, Chung P, Crook J, Gospodarowicz M, McLean M, Ménard C, Milosevic M, Warde P, Catton C. Martin JM, et al. Among authors: bayley a. Int J Radiat Oncol Biol Phys. 2007 Nov 15;69(4):1084-9. doi: 10.1016/j.ijrobp.2007.04.049. Epub 2007 Jul 2. Int J Radiat Oncol Biol Phys. 2007. PMID: 17606331 Clinical Trial.
203 results